Introduction of rotavirus vaccination in Palestine: An evaluation of
When direct healthcare costs and societal costs are taken into account, the incremental cost-effectiveness ratio per gained QALY for Rotarix Õ and RotaTeq Õ are $10 995 and $30 674,